NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.35%62.981.0%$472.19m
AMGNAmgen, Inc. 0.41%241.491.3%$448.51m
BIIBBiogen, Inc. -0.22%285.501.4%$387.69m
ILMNIllumina, Inc. -0.38%324.723.5%$323.34m
VRTXVertex Pharmaceuticals, Inc. 0.14%235.831.9%$300.14m
REGNRegeneron Pharmaceuticals, Inc. 0.10%385.942.6%$230.50m
EXASEXACT Sciences Corp. -1.92%88.0624.0%$205.44m
ALXNAlexion Pharmaceuticals, Inc. 0.68%113.272.0%$195.57m
ITCIIntra-Cellular Therapies, Inc. -1.43%26.259.0%$173.00m
INCYIncyte Corp. -0.15%80.502.5%$148.96m
SRPTSarepta Therapeutics, Inc. -1.84%127.9014.6%$138.72m
ARWRArrowhead Pharmaceuticals, Inc. -1.21%56.4211.3%$132.45m
SGENSeattle Genetics, Inc. 1.25%109.006.1%$122.98m
AAgilent Technologies, Inc. 0.79%90.171.6%$113.52m
BMRNBioMarin Pharmaceutical, Inc. -0.97%88.274.3%$108.30m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.